...
首页> 外文期刊>Cancer genetics >Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer
【24h】

Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer

机译:循环长期非编码RNA MALAT1表达作为埃及乳腺癌患者的分子生物标志物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Highlights ? MALAT1 expression was significantly elevated in breast cancer. ? Sensitivity and specificity were 83.7% and 81.2% for MALAT1 expression. ? Sensitivity and specificity were 77.5% and 82.5% for CA15-3 expression. ? MALAT1 expression possesses a prognostic value of breast cancer. The abnormal contribution of long non-coding RNA (lncRNAs) expression to human tumorigenesis is still a matter of debate. Breast cancer is the most common cancer in females; it represents a terrible problem in our country. The aim of this research was to assess the role of MALAT1, as one of lncRNAs, as a potential biomarker in breast cancer. This study comprised 80 patients with breast cancer and 80 controls. MALAT1 expression was measured by RT-quantitative polymerase chain reaction (qPCR). CA15-3 was estimated using chemiluminescence immunoassay (CLIA). MALAT1 expression was significantly elevated in breast cancer cases compared to controls (P?
机译:强调 ? Malat1表达在乳腺癌中显着升高。 还 MALAT1表达的敏感性和特异性为83.7%和81.2%。 还 CA15-3表达的敏感性和特异性为77.5%和82.5%。 还 Malat1表达具有乳腺癌的预后价值。 长期非编码RNA(LNCRNA)表达对人肿瘤内酯的异常贡献仍然是辩论的问题。 乳腺癌是女性中最常见的癌症; 它代表了我国的一个可怕的问题。 该研究的目的是评估Malat1作为LNCRNA之一的作用,作为乳腺癌的潜在生物标志物。 该研究包括80名乳腺癌和80例对照。 通过RT-定量聚合酶链反应(QPCR)测量Malat1表达。 使用化学发光免疫测定(CLIA)估计CA15-3。 与对照相比,乳腺癌病例中Malat1表达明显升高(P?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号